NCT06513143

Brief Summary

This project aims to combine virtual reality (VR) technologies to construct a metaverse simulation lung surgery platform, which can not only be used as equipment for training novices, but also as a simulated rehearsal before actual surgery, to improve the safety and smoothness of difficult surgeries.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 16, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 22, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 24, 2024

Status Verified

July 1, 2024

Enrollment Period

10 months

First QC Date

July 16, 2024

Last Update Submit

July 22, 2024

Conditions

Keywords

virtual reality (VR)metaversedigital twinssimulated surgery

Outcome Measures

Primary Outcomes (1)

  • questionnaires

    To evaluate the satisfaction levels of students or operators

    Through study completion, an average of 1 year.

Study Arms (1)

Virtual reality surgery

The investigators have completed the translation of personalized 3D models from CT images into virtual 3D models displayed on VR glasses using Synapse (Fujifilm). Additionally, the investigators can illustrate reference CT scans, chart summaries, laboratory data, and other medical information within the VR environment.

Other: CT images into virtual 3D model demonstration

Interventions

The investigators have finished is personalized 3D model translation from CT images into virtual 3D model demonstrated in VR glasses using Synapse.

Virtual reality surgery

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed by surgeons with the following conditions will be included in the eligible group: 1. Complex thoracic surgery, 2. Large mediastinal tumors, 3. Interpulmonary tumors, 4. Patients requiring tracheal transplantation.

You may qualify if:

  • Physicians assess suitable candidates.
  • Consent to the use of their high-resolution computed tomography (CT) scan results as digital simulation material for the establishment of a virtual reality surgical platform.

You may not qualify if:

  • Those without high-resolution computed tomography (CT) scan results.
  • Any conditions and circumstances that the trial principal investigator believes may affect the establishment of the trial platform.
  • Those who have concerns about providing their own CT data.
  • (1) Individuals under the age of 18 are excluded.
  • (2) Any condition or circumstance that the principal investigator deems may affect the establishment of the trial platform.
  • (3) Those who have concerns about providing their own data related to using the surgical simulation platform.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Surgery, National Taiwain University Hospital

Taipei, 100, Taiwan

RECRUITING

Study Officials

  • Xu-Heng Chiang, MD

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Xu-Heng Chiang, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2024

First Posted

July 22, 2024

Study Start

January 1, 2024

Primary Completion

October 30, 2024

Study Completion

December 31, 2024

Last Updated

July 24, 2024

Record last verified: 2024-07

Locations